Adenocarcinoma in situ of the uterine cervix: Clinical practice guidelines from the Italian society of colposcopy and cervical pathology (SICPCV). (September 2019)
- Record Type:
- Journal Article
- Title:
- Adenocarcinoma in situ of the uterine cervix: Clinical practice guidelines from the Italian society of colposcopy and cervical pathology (SICPCV). (September 2019)
- Main Title:
- Adenocarcinoma in situ of the uterine cervix: Clinical practice guidelines from the Italian society of colposcopy and cervical pathology (SICPCV)
- Authors:
- Ciavattini, Andrea
Giannella, Luca
Delli Carpini, Giovanni
Tsiroglou, Dimitrios
Sopracordevole, Francesco
Chiossi, Giuseppe
Di Giuseppe, Jacopo - Abstract:
- Abstract: Objective: to provide a practical tool for the evidenced-based management of adenocarcinoma in situ (AIS) of the uterine cervix, a challenging diagnosis encountered by colposcopists in their daily practice. Methods: the proposed recommendations were drafted by the Italian Society of Colposcopy and Cervical Pathology (SICPCV) based on comprehensive reviews of previous guidelines, large uncontrolled studies, metanalysis, and sytematic reviews. The quality Level and the strength of the recommendations were graded and respectively expressed in Roman numbers (I–VI) and letters (A–E). Results: Women with all subcategories of abnormal glandular cells and AIS on cervical citology should be offered colposcopy with endocervical sampling (Strength of recommendation: A). In women with cytological AIS and negative colposcopy or endocervical curettage, an excisional treatment under colposcopic guidance is recommended (Strength of recommendation: A). If immediate post-conization endocervical sampling is positive, further conization is indicated (Strength of recommendation: C). In women who desire to preserve fertility with positive cone margins, further conization should be performed (Strength of recommendation: B). If colposcopy is adequate, a cylindrical excision that includes the whole transformation zone and at least 1–1.5 cm of endocervix beyond the squamous-columnar junction should be performed (Strength of recommendation: B). If colposcopy is inadequate, it is recommendedAbstract: Objective: to provide a practical tool for the evidenced-based management of adenocarcinoma in situ (AIS) of the uterine cervix, a challenging diagnosis encountered by colposcopists in their daily practice. Methods: the proposed recommendations were drafted by the Italian Society of Colposcopy and Cervical Pathology (SICPCV) based on comprehensive reviews of previous guidelines, large uncontrolled studies, metanalysis, and sytematic reviews. The quality Level and the strength of the recommendations were graded and respectively expressed in Roman numbers (I–VI) and letters (A–E). Results: Women with all subcategories of abnormal glandular cells and AIS on cervical citology should be offered colposcopy with endocervical sampling (Strength of recommendation: A). In women with cytological AIS and negative colposcopy or endocervical curettage, an excisional treatment under colposcopic guidance is recommended (Strength of recommendation: A). If immediate post-conization endocervical sampling is positive, further conization is indicated (Strength of recommendation: C). In women who desire to preserve fertility with positive cone margins, further conization should be performed (Strength of recommendation: B). If colposcopy is adequate, a cylindrical excision that includes the whole transformation zone and at least 1–1.5 cm of endocervix beyond the squamous-columnar junction should be performed (Strength of recommendation: B). If colposcopy is inadequate, it is recommended that conization includes the whole transformation zone with a depth of 20–25 mm (Strength of recommendation: B). Hysterectomy is the standard definitive treatment for AIS in women who do not wish to preserve fertility (Strength of recommendation: B). Conclusion: the proposed recommendations should enable clinicians to correctly diagnose, treat and follow AIS patients, avoiding mismanagement. … (more)
- Is Part Of:
- European journal of obstetrics, gynecology, and reproductive biology. Volume 240(2019)
- Journal:
- European journal of obstetrics, gynecology, and reproductive biology
- Issue:
- Volume 240(2019)
- Issue Display:
- Volume 240, Issue 2019 (2019)
- Year:
- 2019
- Volume:
- 240
- Issue:
- 2019
- Issue Sort Value:
- 2019-0240-2019-0000
- Page Start:
- 273
- Page End:
- 277
- Publication Date:
- 2019-09
- Subjects:
- Adenocarcinoma in situ -- Cervix -- AIS -- Guidelines -- SICPCV
Obstetrics -- Periodicals
Gynecology -- Periodicals
Reproductive health -- Periodicals
Gynecology -- Periodicals
Obstetrics -- Periodicals
Reproduction -- Periodicals
Obstétrique -- Périodiques
Gynécologie -- Périodiques
Reproduction -- Périodiques
Verloskunde
Gynaecologie
Voortplanting (biologie)
Gynecology
Obstetrics
Reproduction
Electronic journals
Periodicals
Electronic journals
618.05 - Journal URLs:
- http://www.sciencedirect.com/science/journal/03012115 ↗
http://www.ingentaconnect.com/content/els/00282243 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/03012115 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/03012115 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.ejogrb.2019.07.014 ↗
- Languages:
- English
- ISSNs:
- 0301-2115
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.733000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 11434.xml